DE602004032164D1 - Zusammensetzungen mit neramexan - Google Patents

Zusammensetzungen mit neramexan

Info

Publication number
DE602004032164D1
DE602004032164D1 DE602004032164T DE602004032164T DE602004032164D1 DE 602004032164 D1 DE602004032164 D1 DE 602004032164D1 DE 602004032164 T DE602004032164 T DE 602004032164T DE 602004032164 T DE602004032164 T DE 602004032164T DE 602004032164 D1 DE602004032164 D1 DE 602004032164D1
Authority
DE
Germany
Prior art keywords
neramexan
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004032164T
Other languages
English (en)
Inventor
Mahendra G Dedhiya
Shashank Mahashabde
Yan Yang
Anshu Goel
Erhard Seiller
Bernhard Hauptmeier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merz Pharma GmbH and Co KGaA
Original Assignee
Merz Pharma GmbH and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34572981&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602004032164(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merz Pharma GmbH and Co KGaA filed Critical Merz Pharma GmbH and Co KGaA
Publication of DE602004032164D1 publication Critical patent/DE602004032164D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602004032164T 2003-11-05 2004-11-05 Zusammensetzungen mit neramexan Active DE602004032164D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51798103P 2003-11-05 2003-11-05
PCT/US2004/037026 WO2005044228A2 (en) 2003-11-05 2004-11-05 Compositions comprising cyclohexylamines and aminoadamantanes

Publications (1)

Publication Number Publication Date
DE602004032164D1 true DE602004032164D1 (de) 2011-05-19

Family

ID=34572981

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004032164T Active DE602004032164D1 (de) 2003-11-05 2004-11-05 Zusammensetzungen mit neramexan

Country Status (19)

Country Link
US (4) US20070270500A1 (de)
EP (2) EP2289489B1 (de)
AR (1) AR046314A1 (de)
AT (1) ATE504290T1 (de)
AU (1) AU2004287489B9 (de)
CA (1) CA2543865C (de)
CL (1) CL2008000125A1 (de)
CY (1) CY1111456T1 (de)
DE (1) DE602004032164D1 (de)
DK (1) DK1684715T3 (de)
ES (2) ES2507500T3 (de)
HR (1) HRP20110482T1 (de)
IL (1) IL175623A (de)
PL (1) PL1684715T3 (de)
PT (1) PT1684715E (de)
SI (1) SI1684715T1 (de)
TW (1) TWI350750B (de)
WO (1) WO2005044228A2 (de)
ZA (1) ZA200603561B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101389315A (zh) * 2004-06-17 2009-03-18 莫茨药物股份两合公司 美金刚口服剂型即释制剂
US20060002999A1 (en) * 2004-06-17 2006-01-05 Forest Laboratories, Inc. Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
US20070060887A1 (en) * 2005-08-22 2007-03-15 Marsh David A Ophthalmic injector
TW200916091A (en) * 2007-06-08 2009-04-16 Merz Pharma Gmbh & Amp Co Kgaa Neramexane for the treatment of nystagmus
ES2596262T3 (es) * 2007-09-12 2017-01-05 Merz Pharma Gmbh & Co. Kgaa Derivados de 1-amino-alquilciclohexano para su uso en el tratamiento de tinnitus asociado con pérdida de audición
TW201006463A (en) * 2008-06-26 2010-02-16 Merz Pharma Gmbh & Co Kgaa Pharmaceutical compositions comprising aminocyclohexane derivatives
TWI432188B (zh) * 2008-12-19 2014-04-01 Merz Pharma Gmbh & Co Kgaa 供治療發炎性皮膚疾病之１－胺基－烷基環己烷衍生物類
CN102159201A (zh) 2008-12-19 2011-08-17 莫茨药物股份两合公司 用于治疗肥大细胞介导的疾病的1-氨基-烷基环己烷衍生物
RU2013102263A (ru) 2010-06-18 2014-07-27 Мерц Фарма Гмбх Унд Ко. Кгаа Гелевые лекарственные формы для местного применения производных 1-аминоалкилциклогексана

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES413944A1 (es) 1972-04-20 1976-06-01 Merz & Co Procedimiento para la preparacion de compuestos de adamen- tano trisustituidos en las posiciones 1,3,5.
DE2856393C2 (de) 1978-12-27 1983-04-28 Merz + Co GmbH & Co, 6000 Frankfurt Arzneimittel zur Behandlung von Morbus Parkinson
US5506231A (en) 1989-03-31 1996-04-09 The Children's Medical Center Corporation Treatment of aids dementia, myelopathy and blindness
US5334618A (en) 1991-04-04 1994-08-02 The Children's Medical Center Corporation Method of preventing NMDA receptor-mediated neuronal damage
ATE94384T1 (de) 1989-04-14 1993-10-15 Merz & Co Gmbh & Co Verwendung von adamantan-derivaten zur praevention und behandlung der cerebralen ischaemie.
US5614560A (en) 1991-04-04 1997-03-25 Children's Medical Center Corporation Method of preventing NMDA receptor-mediated neuronal damage
US5455279A (en) 1991-04-19 1995-10-03 The Children's Medical Center Corporation Regimen method of mediating neuronal damage using nitroglycerine
EP0581856B1 (de) 1991-04-19 1999-07-14 The Children's Medical Center Corporation Verfahren zur vorbeugung nmda-rezeptorkomplex-vermittelter neuronaler schäden
CZ293248B6 (cs) 1997-06-30 2004-03-17 Merz Pharma Gmbh & Co. Kgaa 1-Aminocyklohexanový derivát a farmaceutická kompozice na jeho bázi
US6071966A (en) * 1997-06-30 2000-06-06 Merz + Co. Gmbh & Co. 1-amino-alkylcyclohexane NMDA receptor antagonists
SE9901077D0 (sv) 1999-03-23 1999-03-23 Astra Ab Novel use
US6444702B1 (en) 2000-02-22 2002-09-03 Neuromolecular, Inc. Aminoadamantane derivatives as therapeutic agents
TW593223B (en) * 2000-06-20 2004-06-21 Merz Pharma Gmbh & Co Kgaa 1-amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists
JP2004515477A (ja) * 2000-12-07 2004-05-27 ニューロモレキュラー インコーポレイテッド Ｎｍｄａレセプターアンタゴニストを用いて神経精神医学的障害を処置するための方法
US6828462B2 (en) * 2001-11-07 2004-12-07 Merz Pharma Gmbh & Co. Kgaa Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists
EP1523309A2 (de) * 2002-07-19 2005-04-20 Khalid Iqbal Nmda rezeptor antagonisten und deren verwendung in der hemmung abnormaler hyperphosphorilierung von microtubulärem protein tau
RS20050851A (sr) * 2003-05-27 2008-04-04 Forest Laboratories Inc., Kombinacija antagonista nmda receptora i selektivnog inhibitora ponovnog preuzimanja serotonina za lečenje depresije i drugih poremećaja raspoloženja

Also Published As

Publication number Publication date
SI1684715T1 (sl) 2011-07-29
EP2289489A2 (de) 2011-03-02
EP2289489B1 (de) 2014-07-16
CY1111456T1 (el) 2015-08-05
AR046314A1 (es) 2005-11-30
US20070270500A1 (en) 2007-11-22
PL1684715T3 (pl) 2011-09-30
TW200526195A (en) 2005-08-16
WO2005044228A2 (en) 2005-05-19
AU2004287489B9 (en) 2008-10-09
CL2008000125A1 (es) 2008-03-14
US20100035995A1 (en) 2010-02-11
AU2004287489B2 (en) 2008-08-28
DK1684715T3 (da) 2011-07-11
AU2004287489A1 (en) 2005-05-19
PT1684715E (pt) 2011-05-02
CA2543865A1 (en) 2005-05-19
WO2005044228A3 (en) 2006-06-22
ES2362581T3 (es) 2011-07-07
IL175623A (en) 2012-10-31
US20120238631A1 (en) 2012-09-20
EP1684715B1 (de) 2011-04-06
TWI350750B (en) 2011-10-21
EP1684715A2 (de) 2006-08-02
HRP20110482T1 (hr) 2011-07-31
ES2507500T3 (es) 2014-10-15
ATE504290T1 (de) 2011-04-15
CA2543865C (en) 2012-09-04
ZA200603561B (en) 2007-07-25
US20140350114A1 (en) 2014-11-27
EP2289489A3 (de) 2012-06-06

Similar Documents

Publication Publication Date Title
FR2862654B1 (fr) Composition amylacee filmogene
ATE363383T1 (de) Schlingenware
DE10393374D2 (de) Zusammensetzung
SE0500163L (sv) Sammansättning
DE502004011333D1 (de) Polyalkenamine mit verbesserten anwendungseigenschaften
AT502792A5 (de) Düsenanpressvorrichtung
ATE491774T2 (de) Benzinzusammensetzung
FR2863890B1 (fr) Composition immunostimulante
DE60320902D1 (de) Zusammensetzungen mit ausgelöster Freisetzung
DK1704213T3 (da) Petroleumpræparat
DE602004004388D1 (de) Verdickbare zusammensetzungen
DE112004000620D2 (de) Struktoguss
ATA662003A (de) Trink-mundstück
ATE504290T1 (de) Zusammensetzungen mit neramexan
ATE446959T1 (de) Chromenonindole
ATE356555T1 (de) Nahrungsmittelzusammensetzung
DK1633719T3 (da) Substituerede spirobenzazepiner
DE602004000590T8 (de) Harzzusammensetzung
DE10394329D2 (de) Mäanderstent
ATE365529T1 (de) Schweisshemmende zusammensetzungen
ATE406350T1 (de) Prolinylarylacetamide
DE112004002110D2 (de) Behälter-Deckel-Kombination
DE10329218B4 (de) Hotflue
DE502004006442D1 (de) Bauelement
ATA80232004A (de) Kurbelgehäuse